Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Abdominal Surgery Without Skin Incisions

By HospiMedica staff writers
Posted on 20 Feb 2007
A new device enables surgeons to perform procedures through the gastrointestinal tract (GI) without cutting or puncturing the skin of the abdominal wall.

The natural orifice linear cutter (NOLC) is intended for use in the developing field of natural orifice translumenal endoscopic surgery (NOTES). More...
The device combines a 12-mm wide surgical stapling device with a flexible shaft. The NOLC allows surgeons to maneuver through the GI tract, turn corners, and close internal wounds with precisely-fired staples, all without making an incision in the patient's abdomen. Powered digital controls within the NOLC allow the surgeon precise command of the stapling instrument at the end of the shaft. The NOLC was developed by Power Medical Interventions (Langhorne, PA, USA), and has been approved by the U.S. Food and Drug Administration (FDA).

"The NOLC is a device that will enable surgeons to advance laparoscopic surgery and NOTES to improve patient outcomes by reducing the pain, recovery time, and risk of wound infection associated with traditional surgical procedures,” said Ninh Nguyen, M.D., chief of the division of gastrointestinal surgery at the University of California, Irvine Medical Center (USA).

"We expect the NOLC to have a positive impact on surgical practice in many procedures, including high-risk bariatric or 'weight loss' surgery where the ability to partition or 'shrink' the size of the stomach without incisions should reduce the rate of infection, pain, scarring, and recovery time for many patients,” said Michael Whitman, president, CEO, and founder of Power Medical Interventions.

NOTES is performed in the peritoneal space through natural orifices, obviating the need for skin incisions and possibly without general anesthesia.




Related Links:
Power Medical Interventions
University of California, Irvine Medical Center

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.